Commercial leadership across four practice areas
PharmaKonsult partners with biotechnology CEOs and boards on the commercial decisions that define company value—from culture and leadership through launch, rare disease, and therapeutic specialization.
Investment & Asset Value Creation Assessment
Building investment value before the next major development decision.
For Phase 1 and Phase 2 biotechnology companies, the decisions that influence investment and future licensing value are made years before FDA approval.
Drawing on 36 years of successful pharmaceutical commercialization experience, PharmaKonsult evaluates clinical-stage assets and portfolios to identify opportunities that strengthen company value.
The assessment focuses on:
Portfolio priorities: Evaluate assets, indications, and capital allocation opportunities.
Market realities: Assess competition, evolving treatment pathways, physician prescribing decisions, and future market conditions.
Clinical differentiation: Identify evidence gaps, biomarkers, and development decisions that could strengthen investor and partnering interest.
Commercial potential: Examine patient access, reimbursement, treatment infrastructure, and barriers to adoption.
Investor presentation: Develop an investor-ready pitch deck connecting the science to a credible commercial opportunity, supported by verified KOL perspectives where appropriate.
The objective: Strengthen the investment case, improve development priorities, and increase the potential value of future pharmaceutical partnerships.
This is not sales-force preparation. It is about making better development decisions today that can increase company value tomorrow.
Strategic Drug Development & Commercialization Advisory
Strategic advisory across biotechnology drug development and commercialization—helping leadership make the decisions that increase regulatory success, adoption, partnerships and long-term value.
We help companies integrate commercialization into development: market reality, access strategy, physician confidence, and the leadership decisions that determine launch performance.
Commercial Leadership, Culture & Organizational Performance
High-performing commercial organizations are built through exceptional leadership, disciplined execution, and a culture of trust and accountability.
We help biotechnology companies recruit and develop leaders, optimize commercial organizations, and build cultures that sustain long-term performance.
Specialty Therapeutics
Commercial and development strategy across specialty therapeutics, including neuroscience, endocrinology, and other complex disease markets. We help biotechnology companies evaluate clinical differentiation, patient outcomes, market potential, reimbursement, and commercialization strategy.
Rare Disease Commercialization
Rare disease markets require a different commercial model.
We help biotechnology companies understand patient identification, Centers of Excellence, specialist networks, market access, patient services and the commercial infrastructure required to translate innovation into commercial success.
How PharmaKonsult works
Every engagement is grounded in 36 years of commercial leadership—not theoretical consulting. We work alongside CEOs, boards, and commercial leaders to strengthen the decisions that shape organizational performance and long-term market success.
Whether you are building a commercial organization for the first time, preparing for launch, or refining performance in a specialized therapeutic area, our approach is practical, experience-based, and tailored to the realities of biotechnology commercialization.
Who we help
We partner with biotechnology companies preparing for commercialization, launching innovative therapies, or strengthening commercial performance—particularly in rare disease and specialty therapeutics.
- CEOs and boards seeking commercial clarity before and through launch
- Leadership teams building or restructuring commercial organizations
- Companies navigating specialty and rare disease market complexity
- Organizations that need experienced judgment alongside strategy
Start with the right conversation
Explore a practice area above, or reach out directly to discuss where commercial leadership can create the greatest impact for your organization.
